zoledronic

Showing 1 posts of 1 posts found.

Novartis pulls Zometa submission after breast cancer failure

December 13, 2010
Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic

Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …

The Gateway to Local Adoption Series

Latest content